CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 55 filers reported holding CYTOSORBENTS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $33,000 | -38.9% | 22,900 | -8.0% | 0.04% | -32.2% |
| Q2 2022 | $54,000 | -75.2% | 24,900 | -63.6% | 0.06% | -65.1% |
| Q1 2022 | $218,000 | -68.9% | 68,400 | -20.6% | 0.17% | -67.1% |
| Q3 2021 | $701,000 | -32.3% | 86,200 | -37.0% | 0.51% | -33.9% |
| Q2 2021 | $1,035,000 | -14.0% | 136,900 | -1.6% | 0.78% | -13.9% |
| Q1 2021 | $1,204,000 | -99.9% | 139,100 | 0.0% | 0.90% | +0.9% |
| Q4 2020 | $1,111,127,000 | -2.8% | 139,100 | -51.4% | 0.89% | -8.3% |
| Q3 2020 | $1,142,990,000 | +204370.5% | 286,200 | +406.5% | 0.97% | +82.7% |
| Q2 2020 | $559,000 | +107.8% | 56,500 | +61.4% | 0.53% | +102.7% |
| Q1 2020 | $269,000 | +133.9% | 35,000 | +16.7% | 0.26% | +260.3% |
| Q4 2019 | $115,000 | – | 30,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 249,430 | $2,015,000 | 1.24% |
| Manatuck Hill Partners, LLC | 194,100 | $1,568,000 | 0.81% |
| Skylands Capital, LLC | 495,850 | $4,006,000 | 0.66% |
| EAM Global Investors LLC | 78,027 | $630,000 | 0.34% |
| EAM Investors, LLC | 107,531 | $869,000 | 0.24% |
| Granahan Investment Management | 278,170 | $2,248,000 | 0.16% |
| Wealthcare Advisory Partners LLC | 62,079 | $502,000 | 0.10% |
| Avenir Corp | 76,390 | $617,000 | 0.08% |
| Crow Point Partners, LLC | 48,576 | $380,000 | 0.07% |
| Kalos Management, Inc. | 14,700 | $120,000 | 0.06% |